Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adenosine Equilibrative Transporters (ENTs) are a family of membrane proteins that mediate the bidirectional transport of adenosine and other nucleosides across cell membranes. They play a crucial role in regulating extracellular and intracellular adenosine levels, influencing purinergic signaling, energy metabolism, and nucleic acid synthesis. ENTs are targets for adenosine reuptake inhibitors and mediate the cellular entry of nucleoside analog drugs.
Bidirectional/passive transport of nucleosides based on concentration gradients; inhibition of adenosine reuptake
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenosine Equilibrative Transporter (ENT).